339 related articles for article (PubMed ID: 18430786)
1. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis.
Ben Nasr A; Klimpel GR
J Leukoc Biol; 2008 Jul; 84(1):77-85. PubMed ID: 18430786
[TBL] [Abstract][Full Text] [Related]
2. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.
Ben Nasr A; Haithcoat J; Masterson JE; Gunn JS; Eaves-Pyles T; Klimpel GR
J Leukoc Biol; 2006 Oct; 80(4):774-86. PubMed ID: 16857732
[TBL] [Abstract][Full Text] [Related]
3. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
Clay CD; Soni S; Gunn JS; Schlesinger LS
J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
5. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
Cunnion KM; Buescher ES; Hair PS
J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
[TBL] [Abstract][Full Text] [Related]
7. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of complement activation by a secreted Staphylococcus aureus protein.
Lee LY; Höök M; Haviland D; Wetsel RA; Yonter EO; Syribeys P; Vernachio J; Brown EL
J Infect Dis; 2004 Aug; 190(3):571-9. PubMed ID: 15243934
[TBL] [Abstract][Full Text] [Related]
9. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
10. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.
Patarakul K; Cole MF; Hughes CA
Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707
[TBL] [Abstract][Full Text] [Related]
11. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
Weis JJ; Law SK; Levine RP; Cleary PP
J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alternative complement pathway by isolated human glomerular basement membrane.
Williams JD; Czop JK; Abrahamson DR; Davies M; Austen KF
J Immunol; 1984 Jul; 133(1):394-9. PubMed ID: 6373930
[TBL] [Abstract][Full Text] [Related]
13. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
[TBL] [Abstract][Full Text] [Related]
14. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
[TBL] [Abstract][Full Text] [Related]
15. Role of humoral factors in host resistance to the Bacteroides fragilis group.
Bjornson AB
Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
[TBL] [Abstract][Full Text] [Related]
16. An affinity for complement C3 as a possible reason for the potency of naturally occurring antibodies in mediating tissue homeostasis.
Lutz HU; Fasler S; Stammler P
Beitr Infusionsther; 1989; 24():193-9. PubMed ID: 2481539
[TBL] [Abstract][Full Text] [Related]
17. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.
Kuo CF; Lin YS; Chuang WJ; Wu JJ; Tsao N
Infect Immun; 2008 Mar; 76(3):1163-9. PubMed ID: 18174338
[TBL] [Abstract][Full Text] [Related]
18. Activation of the complement system by Francisella tularensis lipopolysaccharide.
Fulop M; Webber T; Manchee R
New Microbiol; 1993 Apr; 16(2):141-7. PubMed ID: 8510568
[TBL] [Abstract][Full Text] [Related]
19. Complement amplification revisited.
Lutz HU; Jelezarova E
Mol Immunol; 2006 Jan; 43(1-2):2-12. PubMed ID: 16023211
[TBL] [Abstract][Full Text] [Related]
20. Activation of human complement by Yersinia enterocolitica: ultrastructural alterations and C3b-deposition.
Acker G; Brade V
Zentralbl Bakteriol A; 1980 Nov; 248(2):210-28. PubMed ID: 7223121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]